Your browser doesn't support javascript.
loading
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates.
Chen, Evan C; Gandler, Helen; Tosic, Isidora; Fell, Geoffrey G; Fiore, Ashlee; Pozdnyakova, Olga; DeAngelo, Daniel J; Galinsky, Ilene; Luskin, Marlise R; Wadleigh, Martha; Winer, Eric S; Leonard, Rebecca; O'Day, Kelsey; de Jonge, Adrienne; Neuberg, Donna; Look, A Thomas; Stone, Richard M; Frank, David A; Garcia, Jacqueline S.
Afiliação
  • Chen EC; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Gandler H; College of Medicine, University of Vermont, Burlington, Vermont.
  • Tosic I; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Fell GG; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Fiore A; CRISPR Therapeutics, Cambridge, Massachusetts.
  • Pozdnyakova O; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • DeAngelo DJ; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Galinsky I; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Luskin MR; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Wadleigh M; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Winer ES; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Leonard R; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • O'Day K; Bluebird Bio, Cambridge, Massachusetts.
  • de Jonge A; Karyopharm Therapeutics, Boston, Massachusetts.
  • Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Look AT; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Stone RM; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Frank DA; Division of Hematology, Winship Cancer Institute of Emory University, Atlanta, Georgia.
  • Garcia JS; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.
Clin Cancer Res ; 29(5): 878-887, 2023 03 01.
Article em En | MEDLINE | ID: mdl-36534523
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article